Cleared Traditional

K002706 - ROCHE DIAGNOSTICS TINA-QUANT D-DIMER ON COBAS INTEGRA (FDA 510(k) Clearance)

Also includes:
ROCHE DIAGNOSTICS TINA-QUANT D-DIMER ON HITACHI
Mar 2001
Decision
198d
Days
Class 2
Risk

K002706 is an FDA 510(k) clearance for the ROCHE DIAGNOSTICS TINA-QUANT D-DIMER ON COBAS INTEGRA. This device is classified as a Fibrinogen And Fibrin Split Products, Antigen, Antiserum, Control (Class II - Special Controls, product code DAP).

Submitted by Roche Diagnostics Corp. (Indianapolis, US). The FDA issued a Cleared decision on March 16, 2001, 198 days after receiving the submission on August 30, 2000.

This device falls under the Hematology FDA review panel. Regulated under 21 CFR 864.7320.

Submission Details

510(k) Number K002706 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 30, 2000
Decision Date March 16, 2001
Days to Decision 198 days
Submission Type Traditional
Review Panel Hematology (HE)
Summary Summary PDF

Device Classification

Product Code DAP — Fibrinogen And Fibrin Split Products, Antigen, Antiserum, Control
Device Class Class II - Special Controls
CFR Regulation 21 CFR 864.7320